Sirolimus Use in Angioplasty for Vascular Access Extension
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
Dialysis patients presenting for angioplasty intervention for graft failure will be
randomized to receive either Sirolimus or not receive Sirolimus (standard of care) to assess
the time from primary failure or angioplasty intervention to second or next angioplasty
intervention or graft failure.